Research/art/teacher profile of a person
Name and surname:
Mgr. Lucia Kučerová, DrSc.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Kučerová
I.2 - Name
Lucia
I.3 - Degrees
MSc, DSc
I.4 - Year of birth
1973
I.5 - Name of the workplace
Translational Research Unit, 2nd Oncology Clinic, Medical Faculty, Comenius University
I.6 - Address of the workplace
Klenová 1, 833 10 Bratislava - Nové Mesto
I.7 - Position
research scientist
I.8 - E-mail address
lucia.kucerova@fmed.uniba.sk
I.10 - Name of the study field in which a person works at the university
experimental oncology, cellular biology
I.11 - ORCID iD
0000-0002-6407-6659

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Faculty of Natural Sciences, Comenius University
II.b - Year
1994
II.c - Study field and programme
Biochemistry
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Natural Sciences, Comenius University
II.b - Year
1996
II.c - Study field and programme
Biochemistry
II.3 - Third degree of higher education
II.a - Name of the university or institution
Faculty of Medicine, Comenius University
II.b - Year
1999
II.c - Study field and programme
Oncology
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)
II.a - Name of the university or institution
Scientific Board, Slovak Academy of Sciences
II.b - Year
2018
II.c - Study field and programme
Biological Sciences

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Independent researcher Cancer Research Institute SAS 1999-2015
Principal investigator - senior researcher Cancer Research Institute, Biomedical Research Center SAS 2016-present
Research scientist Translational Research Unit, 2nd Oncology Clinic, Medical Faculty, Comenius University 2022-present
Senior research manager Glycostem BV, Oss, the Netherlands 2019-2023

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
State exam English language C1, 12.1.1994 Faculty of Natural Sciences, Comenius University 1994

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.2.a - Name of the study programme V.2.b - Degree V.2.c - Field of study
Oncology III. General Medicine
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
1
V.4.b - Diploma (second degree)
1
V.4.c - Dissertation (third degree)
1
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
1
V.4.b - Diploma (second degree)
1
V.4.c - Dissertation (third degree)
5
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
196
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
68
VI.1.b - Over the last six years
34
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
2873
VI.1.b - Over the last six years
1256
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
1395
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
8
VI.1.b - Over the last six years
2
VI.2 - The most significant research/artistic/other outputs
1

Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy, Authors: Kucerova, Lucia; Altanerova, Veronika; Matuskova, Miroslava; ... Altaner, Cestmir; Published:Jul 2007 in Cancer Research, DOI: 10.1158/0008-5472.CAN-06-4024

2

Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. Mikula, M; Schreiber, M; Husak, Z, Kucerova, L; Ruth, J ; Wieser, R ; Zatloukal, K ; Beug, H ; Wagner, EF; Baccarini, M. )Published:Apr 2001 in The EMBO Journal, DOI: 10.1093/EMBOJ/20.8.1952

3

Tumor cell behaviour modulation by mesenchymal stromal cells. Kucerova, Lucia; Matuskova, Miroslava; Hlubinova, Kristina; ... Altaner, Cestmir; Published:May 2010 in Molecular Cancer, DOI: 10.1186/1476-4598-9-129

4

Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice. Kucerova, Lucia; Matuskova, Miroslava; Pastorakova, Andrea; ... Altaner, Cestmir; Published:Oct 2008 in Journal of Gene Medicine, DOI: 10.1002/JGM.1239

5

Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells. Kucerova, Lucia; Skolekova, Svetlana; Matuskova, Miroslava; ... Kozovska, Zuzana; Published: 2013 in BMC Cancer

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Chemotherapy-triggered changes in stromal compartment drive tumor invasiveness and progression of breast cancer. Plava, Jana; Burikova, Monika; Cihova, Marina; ... Kucerova, Lucia, Miklikova, Svetlana; Published: Sep 2021 in Journal of Experimental & Clinical Cancer Research, DOI: 10.1186/S13046-021-02087-2

2

Genetic Engineering of Natural Killer Cells for Enhanced Antitumor Function, Mantesso, Simone; Geerts, Dirk; Spanholtz, Jan; Kucerova, Lucia, Published: Dec 2020 in Frontiers in Immunology, DOI: 10.3389/FIMMU.2020.607131

3

Permanent Pro-Tumorigenic Shift in Adipose Tissue-Derived Mesenchymal Stromal Cells Induced by Breast Malignancy. Plava, Jana; Cihova, Marina; Burikova, Monika; ... Kucerova, Lucia, Miklikova, Svetlana; Published: Feb 2020 in Cells, DOI: 10.3390/CELLS9020480

4

Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer. Plava, Jana; Cihova, Marina; Burikova, Monika; ... Kucerova, Lucia, Miklikova, Svetlana; Published: Mar 2019 in Molecular Cancer, DOI: 10.1186/S12943-019-0960-Z

5

SCHMIDTOVÁ, Silvia - UDVORKOVÁ, Natália - ČIERNA, Zuzana - HORAK, Samuel - KAĽAVSKÁ, Katarína - CHOVANEC, Michal - ROJIKOVÁ, Lucia - VULEVOVÁ, Miriam - KUČEROVÁ, Lucia* - MEGO, Michal*. Effect of the PARP inhibitor veliparib on germ cell tumor cell lines. In Oncology Letters, 2022, vol.24, no. 5, art. no. 392. (2021: 3.111 - IF, Q3 - JCR, 0.639 - SJR, Q3 - SJR). Typ: ADMA

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

The work was cited more then 2873 times, Hirsch index H=26.Publication: Kucerova L et al., Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer. 2010 May 28;9:129. doi: 10.1186/1476-4598-9-129. Cited in: Di Franco S et al., Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery. Nat Commun. 2021 Aug 18;12(1):5006. doi: 10.1038/s41467-021-25333-9.

2

Publication: Kucerova L et al., Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer. 2010 May 28;9:129. doi: 10.1186/1476-4598-9-129. Cited in: Ridge SM et al., Mesenchymal stem cells: key players in cancer progression. Mol Cancer. 2017 Feb 1;16(1):31. doi: 10.1186/s12943-017-0597-8

3

Publication: Kucerova L et al., Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res. 2007 Jul 1;67(13):6304-13. doi: 10.1158/0008-5472. Cited in: Yin Z et al., Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy. Mol Cancer. 2018 Dec 28;17(1):178. doi: 10.1186/s12943-018-0926-6. 

4

Publication: Kucerova L et al., Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res. 2007 Jul 1;67(13):6304-13. doi: 10.1158/0008-5472. Cited in: Srifa W et al., Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice. Nat Commun. 2020 May 18;11(1):2470. doi: 10.1038/s41467-020-16065-3

5

Publication: Kucerova & Skolekova, Tumor microenvironment and the role of mesenchymal stromal cells. Neoplasma. 2013;60(1):1-10. doi: 10.4149/neo_2013_001. Cited in: Daunys S et al., 3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticles. Adv Exp Med Biol. 2021;1295:243-270. doi: 10.1007/978-3-030-58174-9_11.

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

7th Joint Transnational Call for Proposals of the EuroNanomed Initiative in EuroNanoMed II Projekt INNOCENT, 2017-2020, Consortium coordinator/coinvestigator since 2018

2

APVV-16-0178 Mechanizmus tolerancie indukovanej mezenchýmovými stromálnymi bunkami voči protinádorovej liečbe a cielená terapeutická intervencia v nádorových bunkách karcinómu prsníka, (2016-2021) Principal investigator

3

APVV-16-0010 Identifikácia a validácia signálnych dráh asociovaných s cirkulujúcimi nádorovými bunkami pri karcinóme prsníka, (2016-21) Zodpovedný riešiteľ: prof. MUDr. Michal Mego, DrSc., Principal investigator CRI BMC SAS

4

APVV-15-0697 Úloha CA IX v adaptácii na nádorové mikroprostredie a v rezistencii na protinádorovú terapiu: molekulárne mechanizmy a klinické implikácie, (2015-2020) Co- investigator CRI BMC SAS

5

APVV-21-0158 Identification of new treatment options in refractory testicular germ cell tumors, (2021-2025) Co- investigator

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position VII.b - Name of the institution, board VII.c - Duration
Member of the dosctoral study program, oncoolgy 7.1.15 Comenius University in Bratislava, Faculty of Medicine 2016-present
Member of the Board for the PhD theses defense Comenius University in Bratislava, Faculty of Medicine 2016-present
Member VEGA, Meber of the Comission VEGA nr. 9 for medical and pharmaceutical sciences Slovak Academy of Sciences 2014-2018
Scientific board member Cancer Resrarch Institute SAS 2011-2015

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update
2024-04-26